Cognitive Performance & Cellular Anti-Aging NAD + IV + Glutathione 180 min | 5 medical credits NAD+ is a coenzyme essential to mitochondrial function, DNA repair, and cellular energy metabolism
Primary outcomes were total body weight loss percentage after 12 months of semaglutide treatment based on hormone therapy use status, the percentage of women who achieved 5% or greater and 10% or greater total body weight loss, and changes in glucose, blood pressure and lipids at 12 months
Wu, Y., Sarkissyan, M., Mcghee, E., Lee, S
Semaglutide is primarily approved by the FDA (Food and Drug Administration) for the treatment of type 2 diabetes